- Bioresorbable scaffold implantation in STEMI patients: 5 years imaging subanalysis of PRAGUE-19 study2020 | First Faculty of Medicine, Third Faculty of Medicine
- Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial2019 | Third Faculty of Medicine
- Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial2018 | Third Faculty of Medicine
- Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study2020 | Third Faculty of Medicine
- Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study2016 | First Faculty of Medicine, Third Faculty of Medicine
- Bioresorbable vascular scaffold versus metallic drug-eluting stent in patients at high risk of restenosis: the COMPARE- ABSORB randomised clinical trial2020 | Third Faculty of Medicine
- One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction The PRAGUE-19 Study2015 | Third Faculty of Medicine
- Stent Selection for Primary Angioplasty and Outcomes in the Era of Potent Antiplatelets. Data from the Multicenter Randomized Prague-18 Trial2021 | First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- Antiplatelet therapy after BVS implantation2017 | First Faculty of Medicine
- Coronary stents2017 | Faculty of Medicine in Hradec Králové